Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Explore clinical trials studying Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

4 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Relapsed/Refractory B-cell Non-Hodgkin Lymphoma trial results

Recruiting

NCT07073833

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China

Recruiting

NCT07376642

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Beijing GoBroad Boren Hospital Beijing, Beijing Municipality, China

Zhengzhou Yihe Hospital Zhengzhou, Henan, China

The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

Not Yet Recruiting

NCT07234045

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: China Institute of Hematology and Blood Diseases Hospital Tianjin, Tianjin Municipality, China

Completed

NCT02625480

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital of Orange County Orange, California, United States

UCSF Benioff Children's Hospital San Francisco, California, United States

University of Miami Hospital & Clinics Miami, Florida, United States

View all 30 locations